HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Dammann, C. E. L. Articles by Nielsen, H. C. Search for Related Content PubMed PubMed Citation Articles by Dammann, C. E. L. Articles by Nielsen, H. C.

ErbB receptor regulation by dexamethasone in mouse type II epithelial cells

¹ Dept of Pediatrics, Division of Newborn Medicine, Tufts University and Floating Hospital for Children, Boston, MA, USA, ² Dept of Paediatric Pulmonology and Neonatology, Hannover Medical School, Hannover, Germany.

CORRESPONDENCE: C. E. L. Dammann, Dept of Paediatrics, Hannover Medical School, Carl-Neuberg-Str.1, 30625 Hannover, Germany, Fax: 49 5115326827. E-mail: dammann.christiane{at}mh-hannover.de

Keywords: Dimerisation, epidermal growth factor, neuregulin, phospholipase C, surfactant synthesis

Received: November 11, 2005
Accepted July 14, 2006

Glucocorticoids stimulate foetal surfactant synthesis. Therefore, they are used in impending pre-term birth. One mechanism of action on surfactant synthesis is through the induction of neuregulin (NRG) secretion by foetal lung fibroblasts. The direct effects on signalling pathways, and specifically on erbB receptors in foetal type II cell surfactant synthesis, are less well understood.

The present authors studied the effect of known promoters of foetal surfactant synthesis (namely dexamethasone and mature (i.e. NRG-containing) fibroblast-conditioned medium (FCM)) on erbB receptor activation, protein content and dimerisation patterns in foetal mouse lung type II cells.

Dexamethasone inhibited surfactant synthesis in immature type II cells at day (d)16 of gestation, while the mature FCM had stimulatory effects. Both treatments directly stimulated surfactant synthesis in more mature (d17) cells. At this gestational day, dexamethasone had only a small effect on phosphorylation, but it stimulated the protein levels of all four erbB receptors. Dexamethasone effects were distinct from those of mature FCM, which stimulated both protein content and phosphorylation of all erbB receptors and of the signalling intermediate phospholipase C. Dexamethasone modulated erbB receptor dimerisation patterns, such that erbB2 became the main dimerisation partner for erbB4.

In conclusion, dexamethasone signalling involves erbB receptors in foetal type II cells, in a manner similar to, but distinct from, neuregulin-containing fibroblast-conditioned medium signalling.

This article has been cited by other articles:

				E. Purevdorj, K. Zscheppang, H. G. Hoymann, A. Braun, D. von Mayersbach, M.-J. Brinkhaus, A. Schmiedl, and C. E. L. Dammann ErbB4 deletion leads to changes in lung function and structure similar to bronchopulmonary dysplasia Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L516 - L522. [Abstract] [Full Text] [PDF]